Literature DB >> 2939790

Concepts of clot lysis.

C W Francis, V J Marder.   

Abstract

Physiologic thrombolysis is efficient, while pathologic aberrations in the fibrinolytic system may result in either thrombotic or hemorrhagic disease. This review considers the molecular interactions involved in fibrinolysis, discusses the normal control mechanisms that provide for localized activation without systemic effects, and describes the molecular mechanism of plasmic degradation of fibrinogen and of cross-linked fibrin. The consequences of excessive or deficient fibrinolysis are discussed and specific examples cited of pathologic hemostasis directly related to abnormalities in the fibrinolytic system.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2939790     DOI: 10.1146/annurev.me.37.020186.001155

Source DB:  PubMed          Journal:  Annu Rev Med        ISSN: 0066-4219            Impact factor:   13.739


  6 in total

1.  Circulatory concentrations of fibrinolytic species during thrombolytic therapy estimated by stirred-tank reactor analysis.

Authors:  V V Tuliani; E A O'Rear
Journal:  Pharm Res       Date:  1997-08       Impact factor: 4.200

2.  Synergistic fibrinolysis: combined effects of plasminogen activators and an antibody that inhibits alpha 2-antiplasmin.

Authors:  G L Reed; G R Matsueda; E Haber
Journal:  Proc Natl Acad Sci U S A       Date:  1990-02       Impact factor: 11.205

3.  Detection of experimental thrombi in rabbits with an 131I-labelled fibrin-specific monoclonal antibody.

Authors:  K Z Walker; L J Milner; G J Bautovich; P Borham; A K Wood; D B Rylatt; P Martin; P G Bundesen; G R Boniface
Journal:  Eur J Nucl Med       Date:  1990

4.  Inhibition of plasmin by fibrinogen.

Authors:  A A Higazi; M Mayer
Journal:  Biochem J       Date:  1990-07-15       Impact factor: 3.857

5.  Bleeding diathesis due to decreased functional activity of type 1 plasminogen activator inhibitor.

Authors:  R R Schleef; D L Higgins; E Pillemer; L J Levitt
Journal:  J Clin Invest       Date:  1989-05       Impact factor: 14.808

6.  Fibrin-based tissue engineering scaffolds enhance neural fiber sprouting and delay the accumulation of reactive astrocytes at the lesion in a subacute model of spinal cord injury.

Authors:  Philip J Johnson; Stanley R Parker; Shelly E Sakiyama-Elbert
Journal:  J Biomed Mater Res A       Date:  2010-01       Impact factor: 4.396

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.